Imagine a future where we have control over our bodies and lives, enabling radically improved, seamlessly experienced healthcare. When we can control our neural signals to prevent the deterioration in our health. These objectives are very much in the mind of Oliver Armitage, founder and CSO of BIOS, a company based in Cambridge, UK.
BIOS uses neural interfaces and AI to discover the language of the nervous system – a code known as digital neural biomarkers. By leveraging these unique biomarkers, the BIOS Autonomic Therapy Initiative (ATI) offers precision unseen before in healthcare - giving personalized, real-time treatment recommendations, shaping the design of new therapies and even replacing current drugs with computer-generated neural signals.
Armitage’s personal lifelong pursuit is to find a solution which enables man and machine to work seamlessly together. Along with his team he is working on a project that could change the lives of amputees around the world.
Don’t miss Armitage’s talk at and& Leuven which promises to open our eyes to an exciting new future for innovative healthcare.